| Thromboembolic, bleeding, and mortality risks of rivaroxaban and dabigatran in Asians with nonvalvular atrial fibrillation YH Chan, CT Kuo, YH Yeh, SH Chang, LS Wu, HF Lee, HT Tu, LC See Journal of the American College of Cardiology 68 (13), 1389-1401, 2016 | 172 | 2016 |
| Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in Asians with nonvalvular atrial fibrillation YH Chan, LC See, HT Tu, YH Yeh, SH Chang, LS Wu, HF Lee, CL Wang, ... Journal of the American Heart Association 7 (8), e008150, 2018 | 148 | 2018 |
| Effectiveness and safety of four direct oral anticoagulants in Asian patients with nonvalvular atrial fibrillation YH Chan, HF Lee, LC See, HT Tu, TF Chao, YH Yeh, LS Wu, CT Kuo, ... Chest 156 (3), 529-543, 2019 | 111 | 2019 |
| Cardiovascular, bleeding, and mortality risks of dabigatran in Asians with nonvalvular atrial fibrillation YH Chan, KC Yen, LC See, SH Chang, LS Wu, HF Lee, HT Tu, YH Yeh, ... Stroke 47 (2), 441-449, 2016 | 100 | 2016 |
| Acute kidney injury in Asians with atrial fibrillation treated with dabigatran or warfarin YH Chan, YH Yeh, LC See, CL Wang, SH Chang, HF Lee, LS Wu, HT Tu, ... Journal of the American College of Cardiology 68 (21), 2272-2283, 2016 | 83 | 2016 |
| Effectiveness and safety of non–vitamin k antagonist oral anticoagulant and warfarin in cirrhotic patients with nonvalvular atrial fibrillation HF Lee, YH Chan, SH Chang, HT Tu, SW Chen, YH Yeh, LS Wu, CF Kuo, ... Journal of the American Heart Association 8 (5), e011112, 2019 | 78 | 2019 |
| Association of blood group A with coronary artery disease in young adults in Taiwan HF Lee, YC Lin, CP Lin, CL Wang, CJ Chang, LA Hsu Internal Medicine 51 (14), 1815-1820, 2012 | 75 | 2012 |
| Incremental prognostic value of global myocardial work over ejection fraction and global longitudinal strain in patients with heart failure and reduced ejection fraction CL Wang, YH Chan, VCC Wu, HF Lee, FC Hsiao, PH Chu European Heart Journal-Cardiovascular Imaging 22 (3), 348-356, 2021 | 70 | 2021 |
| Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation YH Chan, TF Chao, SW Chen, HF Lee, YH Yeh, YC Huang, SH Chang, ... Heart rhythm 17 (12), 2102-2110, 2020 | 67 | 2020 |
| Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan CY Chang, YH Yeh, YH Chan, JR Liu, SH Chang, HF Lee, LS Wu, ... Cardiovascular diabetology 16, 1-10, 2017 | 56 | 2017 |
| The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation HF Lee, YH Chan, HT Tu, CT Kuo, YH Yeh, SH Chang, LS Wu, LC See International journal of cardiology 261, 78-83, 2018 | 39 | 2018 |
| Prognostic value of global left ventricular strain for conservatively treated patients with symptomatic aortic stenosis HF Lee, LA Hsu, YH Chan, CL Wang, CJ Chang, CT Kuo Journal of cardiology 62 (5), 301-306, 2013 | 38 | 2013 |
| Prognostic significance of dilated inferior vena cava in advanced decompensated heart failure HF Lee, LA Hsu, CJ Chang, YH Chan, CL Wang, WJ Ho, PH Chu The International Journal of Cardiovascular Imaging 30, 1289-1295, 2014 | 35 | 2014 |
| Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants YH Chan, HF Lee, PR Li, JR Liu, TF Chao, LS Wu, SH Chang, YH Yeh, ... Cardiovascular diabetology 19, 1-14, 2020 | 34 | 2020 |
| Effectiveness and safety of direct oral anticoagulants in an Asian population with atrial fibrillation undergoing dialysis: a population-based cohort study and meta-analysis LC See, HF Lee, TF Chao, PR Li, JR Liu, LS Wu, SH Chang, YH Yeh, ... Cardiovascular Drugs and Therapy 35, 975-986, 2021 | 33 | 2021 |
| Real-world comparisons of direct oral anticoagulants for stroke prevention in Asian patients with non-valvular atrial fibrillation: a systematic review and meta-analysis YH Chan, HF Lee, TF Chao, CT Wu, SH Chang, YH Yeh, LC See, CT Kuo, ... Cardiovascular Drugs and Therapy 33, 701-710, 2019 | 31 | 2019 |
| Ratio of transmitral early filling velocity to early diastolic strain rate predicts outcomes in patients with systolic heart failure YH Chan, HF Lee, LS Wu, CL Wang, CT Wu, YH Yeh, YWJ Ho, LA Hsu, ... European Heart Journal-Cardiovascular Imaging 18 (1), 79-85, 2017 | 29 | 2017 |
| Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus … HF Lee, SW Chen, JR Liu, PR Li, LS Wu, SH Chang, YH Yeh, CT Kuo, ... Cardiovascular Diabetology 19, 1-12, 2020 | 27 | 2020 |
| Comparisons of rivaroxaban following different dosage criteria (ROCKET AF or J‐ROCKET AF Trials) in Asian patients with atrial fibrillation YH Chan, HF Lee, CL Wang, SH Chang, CH Yeh, TF Chao, YH Yeh, ... Journal of the American Heart Association 8 (21), e013053, 2019 | 22 | 2019 |
| Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation YH Chan, C Chuang, CC Chan, HF Lee, YC Huang, YT Huang, ... Cardiovascular Diabetology 19, 1-14, 2020 | 21 | 2020 |
